Takehiro Fukami Selected Research

Ubiquinone

1/2021	The ubiquinone synthesis pathway is a promising drug target for Chagas disease.
1/2020	Identification of small molecule inhibitors of human COQ7.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takehiro Fukami Research Topics

Disease

8	Body Weight (Weight, Body) 09/2009 - 06/2002
4	Neoplasms (Cancer) 05/2022 - 12/2018
4	Obesity 08/2009 - 06/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 04/2013
2	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 12/2018
2	Hyperphagia (Overeating) 05/2003 - 06/2002
1	Hepatitis B 01/2022
1	Infections 01/2022
1	Viremia 01/2022
1	Chronic Hepatitis B 01/2022
1	Chagas Disease (American Trypanosomiasis) 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2021
1	TDP-43 Proteinopathies 01/2021
1	Coenzyme Q10 Deficiency 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Carcinogenesis 12/2018
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 12/2018
1	Leukemia 04/2013
1	Insulin Resistance 07/2008
1	Weight Loss (Weight Reduction) 10/2006
1	Overweight 10/2006
1	Hypercholesterolemia 05/2003
1	Hyperinsulinism (Hyperinsulinemia) 05/2003
1	Dehydration (Water Stress) 11/2002

Drug/Important Bio-Agent (IBA)

4	TankyrasesIBA 01/2021 - 12/2018
4	Neuropeptide YIBA 08/2009 - 06/2002
3	neuropeptide Y5 receptorIBA 10/2006 - 05/2003
2	UbiquinoneIBA 01/2021 - 01/2020
2	CateninsIBA 01/2020 - 12/2018
1	Lysine (L-Lysine)FDA Link 05/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	myrcludex-BIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2021
1	NifurtimoxIBA 01/2021
1	benzonidazole (benznidazole)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	EnzymesIBA 11/2019
1	LigandsIBA 12/2018
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	TCF Transcription FactorsIBA 12/2018
1	neuropeptide Y-Y1 receptorIBA 08/2009
1	Spironolactone (Aldactone)FDA LinkGeneric 07/2008
1	sibutramine (Meridia)FDA Link 07/2008
1	Insulin (Novolin)FDA Link 07/2008
1	trans- N- (1- (2- fluorophenyl)- 1h- pyrazol- 3- yl)- 1'- oxo- spiro(cyclohexane- 1,3'(1'H)- furo(3,4- C)pyridine)- 4- carboxamideIBA 10/2006
1	Leptin ReceptorsIBA 05/2006
1	ZincIBA 11/2002
1	Silica GelIBA 11/2002
1	AcidsIBA 11/2002
1	AnhydridesIBA 11/2002
1	allyl alcohol (allylic alcohol)IBA 11/2002
1	Indicators and Reagents (Reagents)IBA 11/2002
1	EstersIBA 11/2002
1	CorticosteroneIBA 06/2002

Therapy/Procedure

6	Oral Administration 12/2018 - 06/2002
2	Therapeutics 01/2021 - 12/2018
1	Drug Therapy (Chemotherapy) 04/2013
1	Intraventricular Infusions 05/2003